Toxoplasmosis and treatment for rheumatic diseases: what are the risks?

Autor:	David G. I. Scott, Barbara M. Lund
Rok vydání:	2020
Předmět:	medicine.medical_specialty business.industry MEDLINE medicine.disease Toxoplasmosis Rheumatology Antirheumatic Agents Rheumatic Diseases medicine Animals Humans Pharmacology (medical) Intensive care medicine business
Zdroj:	Rheumatology. 60:5-7
ISSN:	1462-0332 1462-0324
DOI:	10.1093/rheumatology/keaa614
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e5f3209e568605a0f8ff2d2d5e3208d https://doi.org/10.1093/rheumatology/keaa614 Zobrazit plný text záznamu